We have recently shown that circulating adiponectin is inversely associated with risk for acute myelogenous leukaemia (AML) but not acute lymphoblastic leukaemia (ALL) in children (Petridou et al, 2006). Here, ADIPOQ is linked to acute myeloid leukemia.